Shah Gaurav — SEC insider filings

SEC reporting owner CIK 1725922. 37 insider filings on record with FilingPulse; latest filed 2026-11-20.

Transaction summary — filings shown

Covers all 37 filings on record, filed 2021-02-08 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ROCKET PHARMACEUTICALS, INC. (RCKT)CEO352 legs · 42,000 sh · $483,11320 legs · 189,795 sh · $2,059,02948
Talaris Therapeutics, Inc. (TALS)Director2——2

Insider filings — Shah Gaurav

FiledFormIssuerReported transactionsSource
2026-11-204ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 2,216 @ $2.18EDGAR
2026-11-174ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 3,020 @ $2.25EDGAR
2026-08-204ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 2,293 @ $3.38EDGAR
2026-08-174ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 2,837 @ $3.38EDGAR
2026-05-264ROCKET PHARMACEUTICALS, INC. (RCKT)Option exercise (M): 76,490 @ $1.69 · Sale (S): 55,684 @ $3.09 · Option exercise (M): 76,490 (derivative) @ $1.69EDGAR
2026-05-214ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 2,409 @ $3.01EDGAR
2026-05-144ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 2,728 @ $3.61EDGAR
2026-02-204ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 5,990 @ $3.34EDGAR
2026-02-184ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 12,279 @ $3.31EDGAR
2026-02-134ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 286,028 @ $0 · Grant/award (A): 870,648 (derivative) @ $0EDGAR
2025-11-204ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 6,276 @ $2.98EDGAR
2025-08-204ROCKET PHARMACEUTICALS, INC. (RCKT)Tax withholding (F): 2,234 @ $3.05EDGAR
2025-05-224ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 2,253 @ $6.45EDGAR
2025-05-204ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 3,621 @ $6.53EDGAR
2025-04-144ROCKET PHARMACEUTICALS, INC. (RCKT)Purchase (P): 20,000 @ $5.08EDGAR
2025-02-254ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 16,303 @ $10.58EDGAR
2025-02-134ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 81,655 @ $0 · Grant/award (A): 243,345 (derivative) @ $0EDGAR
2024-11-254ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 11,091 @ $13.05EDGAR
2024-08-204ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 9,650 @ $18.50EDGAR
2024-05-204ROCKET PHARMACEUTICALS, INC. (RCKT)Option exercise (M): 7,979 @ $0 · Option exercise (M): 9,683 @ $0 · Other (J): 23,940 @ $0 · Other (J): 67,785 @ $0 · Sale (S): 9,790 @ $23.35 · Option exercise (M): 7,979 (derivative) @ $0 · +3 moreEDGAR
2024-02-214ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 20,272 @ $29.84 · Grant/award (A): 66,577 @ $0 · Grant/award (A): 196,336 (derivative) @ $0EDGAR
2024-02-164ROCKET PHARMACEUTICALS, INC. (RCKT)Option exercise (M): 46,828 @ $0 · Option exercise (M): 7,979 (derivative) @ $0 · Option exercise (M): 38,849 (derivative) @ $0EDGAR
2023-11-164ROCKET PHARMACEUTICALS, INC. (RCKT)Option exercise (M): 7,979 @ $0 · Option exercise (M): 7,979 (derivative) @ $0EDGAR
2023-08-214ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 4,767 @ $15.47EDGAR
2023-08-154ROCKET PHARMACEUTICALS, INC. (RCKT)Option exercise (M): 7,979 @ $0 · Option exercise (M): 7,979 (derivative) @ $0EDGAR
2023-06-144Talaris Therapeutics, Inc. (TALS)Grant/award (A): 20,500 (derivative) @ $0EDGAR
2023-05-194ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 4,122 @ $21.38EDGAR
2023-05-164ROCKET PHARMACEUTICALS, INC. (RCKT)Option exercise (M): 7,979 @ $0 · Option exercise (M): 7,979 (derivative) @ $0EDGAR
2023-02-224/AROCKET PHARMACEUTICALS, INC. (RCKT)Option exercise (M): 31,440 @ $0 · Grant/award (A): 348,590 (derivative) @ $0 · Grant/award (A): 116,317 (derivative) @ $0 · Option exercise (M): 31,440 (derivative) @ $0EDGAR
2023-02-224ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 12,194 @ $19.06EDGAR
2023-02-164ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 348,590 (derivative) @ $0 · Grant/award (A): 116,317 (derivative) @ $0EDGAR
2022-06-134Talaris Therapeutics, Inc. (TALS)Grant/award (A): 14,501 (derivative) @ $0EDGAR
2022-02-164ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 297,037 (derivative) @ $0 · Grant/award (A): 95,275 (derivative) @ $0EDGAR
2022-02-084ROCKET PHARMACEUTICALS, INC. (RCKT)Purchase (P): 22,000 @ $17.34EDGAR
2021-04-014ROCKET PHARMACEUTICALS, INC. (RCKT)Tax withholding (F): 19,984 @ $41.80 · Tax withholding (F): 8,667 @ $42.80 · Tax withholding (F): 48,732 @ $43.86 · Tax withholding (F): 8,505 @ $44.34 · Option exercise (M): 75,880 @ $1.69 · Tax withholding (F): 3,000 @ $45.59 · +3 moreEDGAR
2021-04-014ROCKET PHARMACEUTICALS, INC. (RCKT)Tax withholding (F): 7,493 @ $45.94 · Tax withholding (F): 5,919 @ $45.21 · Tax withholding (F): 8,872 @ $46.45 · Tax withholding (F): 7,475 @ $47.21EDGAR
2021-02-084ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 185,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1725922 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs